SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: UnderCover who wrote (1643)	6/23/1998 4:35:00 PM
From: FatMatty	of 5402

Pher-02 is affective in angioplasity (PTCA ) . Floursol (first generation) was first approved for PTCA in 1989. Your Dad's PCTA probably would have lasted longer than 2 months if they had and used pher-02. It will also be used for bypass both in priming of the heart lung machine and in general transfusion for the blood loss in the bypass. Tom/Sanguine Prospector / care of LT-Z ___ The doctor had told him that the reoccurrence of the blockage was caused by severe clotting around the 'stent' inserted in his artery from the angioplasty. He was participating in a double blind test experiment involving a blood-thinning medicine, and apparently had been receiving the placebo instead of the real thing. The non-clotting properties of pher-02 would have kept the clotting at bay, am I correct on this? Seems like such a product would be ideal in such procedures (and the bypass surgeries), especially in light of A) all the procedures that take place in this country and B) an older population developing as Baby Boomers move into the 50's and 60's. Thanks for the response Tom (sanguine) and Prospector's legwork! Matt

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next